HTA - NIHR128490
PERsonalised Medicine for Intensification of Treatment (PERMIT): the case of type 2 Diabetes Mellitus
Project title: PERsonalised Medicine for Intensification of Treatment (PERMIT): the case of type 2 Diabetes Mellitus
Call to action: 18/80 18/80 HTA Precision Medicine
Research type: Primary Research
Chief investigator: Professor Richard Grieve
Contractor: London School of Hygiene & Tropical Medicine
Cost: £547,546.04
Co-investigators: Associate Professor Stephen O'Neill, Dr Richard Silverwood, Mr Paul Charlton, Professor Amanda Adler, Professor Andrew Briggs, Professor Anirban Basu, Professor Ian Douglas, Professor Kamlesh Khunti, Professor Liam Smeeth.
Started: January 2020 | Status: Research in progress
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research